Swiss National Bank Sells 13,100 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Swiss National Bank decreased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 3.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 408,300 shares of the company’s stock after selling 13,100 shares during the period. Swiss National Bank owned about 0.31% of Henry Schein worth $30,912,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Raymond James Financial Services Advisors Inc. lifted its position in shares of Henry Schein by 15.8% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 7,057 shares of the company’s stock worth $524,000 after buying an additional 965 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Henry Schein by 8.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,528 shares of the company’s stock worth $1,747,000 after purchasing an additional 1,773 shares during the last quarter. Mackenzie Financial Corp grew its stake in Henry Schein by 0.9% in the 3rd quarter. Mackenzie Financial Corp now owns 62,672 shares of the company’s stock valued at $4,577,000 after purchasing an additional 562 shares during the period. Strs Ohio increased its position in shares of Henry Schein by 13.6% during the 3rd quarter. Strs Ohio now owns 30,886 shares of the company’s stock valued at $2,293,000 after purchasing an additional 3,687 shares during the last quarter. Finally, IFM Investors Pty Ltd raised its stake in shares of Henry Schein by 11.8% during the 3rd quarter. IFM Investors Pty Ltd now owns 27,540 shares of the company’s stock worth $2,045,000 after purchasing an additional 2,914 shares during the period. Institutional investors own 96.62% of the company’s stock.

Analyst Ratings Changes

HSIC has been the subject of a number of research analyst reports. Jefferies Financial Group raised their price objective on shares of Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a report on Wednesday, March 6th. TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. Piper Sandler raised their target price on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research report on Monday, February 26th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. Finally, JPMorgan Chase & Co. increased their price target on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 6th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $81.73.

Henry Schein Stock Performance

Henry Schein stock opened at $72.76 on Thursday. The firm’s 50 day simple moving average is $73.01 and its 200 day simple moving average is $72.34. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The firm has a market capitalization of $9.35 billion, a PE ratio of 23.10, a price-to-earnings-growth ratio of 1.68 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.21 billion. During the same quarter last year, the business posted $1.21 earnings per share. The firm’s revenue was up 3.7% compared to the same quarter last year. As a group, analysts expect that Henry Schein, Inc. will post 5.07 earnings per share for the current fiscal year.

Insider Transactions at Henry Schein

In related news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.